Pfizer recalls Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York,…

Recall date

July 29, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0575-2025

FDA classification

Class II

Brand / firm

Pfizer

Sold / distributed

Within U.S

Why it was recalled

Subpotent drug

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.